# Study Investigating the Safety, Tolerability and Blood Concentration of the Substance SR-878

> **NCT06607484** · PHASE1 · TERMINATED · sponsor: **SciRhom GmbH** · enrollment: 18 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** SR-878
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06607484
- **Lead sponsor:** SciRhom GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2024-10-08
- **Primary completion:** 2025-02-27
- **Final completion:** 2025-02-27
- **Target enrollment:** 18 (ACTUAL)
- **Why stopped:** Sponsor decision
- **Last updated:** 2025-06-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06607484

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06607484, "Study Investigating the Safety, Tolerability and Blood Concentration of the Substance SR-878". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06607484. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*